For patients with low naïve CD4+TIL, NCT may increase the infiltration of immune‐activated CD4+TIL, enhance antitumor immunity, and prolong the OS of patients with NCT‐NSCLC. Here, CD4 is linked to non-small cell lung carcinoma.